This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
First Lien Term Loan lenders have agreed to extend the maturity from 2025 to 2029 and amend certain terms thereof. RP is offering to exchange its senior secured notes due in 2025 for new first lien notes due in 2029 and its senior unsecured notes due in 2028 for new second lien notes due in 2030.
The notes will come due in 2029, the company said. Disposable products developer Merit Medical Systems plans to make $550 million of convertible senior notes available for private sale. It also plans to give purchasers of the notes the option to buy an additional $82.5
billion, with the CAGR from 2024-2029 forecast at 4.2% billion market size by 2029. While North America is the largest market, the fastest-growing radiotherapy market is Asia Pacific, estimated to grow at the highest CAGR over the forecast period (2024-2029). In 2024, the Radiotherapy Market size is expected to reach USD 10.18
billion by 2029, according to Maximize Market Research, a global healthcare market research firm. The need for imaging modalities to support an earlier, more accurate diagnosis continues to drive AI applications in the medical imaging market. billion in 2022 to $27.52
billion by 2029. Industry experts predict the pharmaceutical analytical testing market could total an estimated USD 8.98 billion in 2024. These findings forecast the market segment to grow steadily at a CAGR of 8.41%, reaching USD 13.43
billion by 2029, according to Maximize Market Research, a global healthcare market research firm. The need for imaging modalities to support an earlier, more accurate diagnosis continues to drive AI applications in the medical imaging market. The size of the market for AI in medical imaging is experiencing phenomenal growth from $1.12
It should be operational by 2029. NuScale is the only US company to receive approval and certification from the US Nuclear Regulatory Commission (NRC) for manufacturing and selling SMRs. Other leaders in the space include TerraPower, which Bill Gates backs in collaboration with GE Hitachi Nuclear Energy.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content